Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuGenerex Medical Marketing (NMM) was established in 2018 as a subsidiary of Generex Biotechnology Corporation to provide integrated sales and marketing support for the parent company's healthcare portfolio. Based in Miramar, Florida, NMM focused on patient health management services, including patient identification, acquisition, and chronic care support through a HIPAA-compliant call center and proprietary data analytics. The company was designed to facilitate the direct-to-consumer distribution of pharmaceuticals, medical devices, and laboratory services, particularly for chronic conditions such as diabetes and cardiovascular disease. Despite its initial launch as a key component of Generex's reorganization strategy, NMM is currently listed as an inactive entity in recent regulatory filings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuGenerex Medical Marketing.